|

Brigatinib Clinical Trials

3 actively recruiting trials

Also known as: ALUNBRIG, Alunbrig, Alunbrig Tablets

Pipeline

Phase 1/2: 1

Top Sponsors

  • Takeda1
  • Princess Maxima Center for Pediatric Oncology1
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS1

Indications

  • Cancer3
  • Lung Cancer2
  • Sex Disorder1
  • Other Solid Tumor1
  • Inflammatory Myofibroblastic Tumor1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.